Roles of Beta2- and Beta3-adrenoceptor Polymorphisms in Hypertension and Metabolic Syndrome

Overview

Journal Int J Hypertens

Publisher Wiley

Date 2010 Oct 29

PMID 20981286

Citations 13

Authors

Kazuko Masuo

Affiliations

Soon will be listed here.

Abstract

Hypertension, diabetes mellitus (especially type 2 diabetes mellitus), metabolic syndrome and obesity are rapidly growing public health problems. Sympathetic nerve activation is observed in obesity, hypertension and diabetes mellitus, which have strong genetic as well as environmental determinants. Reduced energy expenditure and resting metabolic rate are predictive of weight gain, and the sympathetic nervous system participates in regulating energy balance through thermogenesis. The thermogenic effects of catecholamines in obesity have been mainly mediated via the β2- and β3-adrenergic receptors in humans. Further, β2-adrenoceptors importantly influence vascular reactivity and may regulate blood pressure. Genetic polymorphistns of the β-adrenoceptor gene have been shown to alter the function of several adrenoceptor subtypes and thus to modify the response to catecholamine. β2-adrenoceptor polymorphisms (Arg16Gly, Gln27Glu, and Thr164Ile) have been studied in relation to hypertension. Genetic variations in the β3-adrenoceptor (i.e. Try64Arg variant) are also associated with both obesity and hypertension. However, the precise relationships of the polymorphisms of β2- and β3-adrenoceptor genes with sympathetic nervous system activity, hypertension, and metabolic syndrome have not been fully clarified. This paper will discuss the current topics involving the influence of the sympathetic nervous system and β2- and β3- adrenoceptor polymorphisms in hypertension and metabolic syndrome.

Citing Articles

Diagnosis and prevention of the vasodepressor type of neurally mediated syncope in Japanese patients.

Hasegawa M, Komiyama T, Ayabe K, Sakama S, Sakai T, Lee K PLoS One. 2021; 16(6):e0251450.

PMID: 34170907 PMC: 8232444. DOI: 10.1371/journal.pone.0251450.

The Relationships between Leptin, Genotype, and Chinese Medicine Body Constitution for Obesity.

Hou H, Chen H, Lu J, Chang S, Li H, Jiang K Evid Based Complement Alternat Med. 2021; 2021:5510552.

PMID: 34055005 PMC: 8123988. DOI: 10.1155/2021/5510552.

The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD).

Wang Z, Li S, Wang R, Guo L, Xu D, Zhang T Mol Med. 2020; 26(1):54.

PMID: 32503411 PMC: 7275314. DOI: 10.1186/s10020-020-00164-4.

Genetic variability of five ADRB2 polymorphisms among Mexican Amerindian ethnicities and the Mestizo population.

Salas-Martinez M, Saldana-Alvarez Y, Cordova E, Mendiola-Soto D, Cid-Soto M, Luckie-Duque A PLoS One. 2019; 14(12):e0225030.

PMID: 31790415 PMC: 6886845. DOI: 10.1371/journal.pone.0225030.

Association Between Trp64arg Polymorphism of the β3 adrenoreceptor Gene and Female Sex in Obese Turkish Children and Adolescents.

Yilmaz R, Ates O, Gul A, Kasap T, Ozer S, Ensari E Pediatr Gastroenterol Hepatol Nutr. 2019; 22(5):460-469.

PMID: 31555571 PMC: 6751107. DOI: 10.5223/pghn.2019.22.5.460.

References

Dunajska K, Lwow F, Milewicz A, Jedrzejuk D, Laczmanski L, Belowska-Bien K . beta(3)-adrenergic receptor polymorphism and metabolic syndrome in postmenopausal women. Gynecol Endocrinol. 2008; 24(3):133-8. DOI: 10.1080/09513590801921686. View

Iwashita S, Tanida M, Terui N, Ootsuka Y, Shu M, Kang D . Direct measurement of renal sympathetic nervous activity in high-fat diet-related hypertensive rats. Life Sci. 2002; 71(5):537-46. DOI: 10.1016/s0024-3205(02)01707-1. View

Masuo K, Mikami H, Itoh M, Ogihara T, Tuck M . Sympathetic activity and body mass index contribute to blood pressure levels. Hypertens Res. 2000; 23(4):303-10. DOI: 10.1291/hypres.23.303. View

Heidemann C, Boeing H, Pischon T, Nothlings U, Joost H, Schulze M . Association of a diabetes risk score with risk of myocardial infarction, stroke, specific types of cancer, and mortality: a prospective study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam cohort. Eur J Epidemiol. 2009; 24(6):281-8. DOI: 10.1007/s10654-009-9338-7. View

Ramsey F, Ussery-Hall A, Garcia D, McDonald G, Easton A, Kambon M . Prevalence of selected risk behaviors and chronic diseases--Behavioral Risk Factor Surveillance System (BRFSS), 39 steps communities, United States, 2005. MMWR Surveill Summ. 2008; 57(11):1-20. View

Rasmussen M, Belza A, Almdal T, Toubro S, Bratholm P, Astrup A . Change in beta1-adrenergic receptor protein concentration in adipose tissue correlates with diet-induced weight loss. Clin Sci (Lond). 2004; 108(4):323-9. DOI: 10.1042/CS20040238. View

Arner P . The beta 3-adrenergic receptor--a cause and cure of obesity?. N Engl J Med. 1995; 333(6):382-3. DOI: 10.1056/NEJM199508103330612. View

Ogden C, Fryar C, Carroll M, Flegal K . Mean body weight, height, and body mass index, United States 1960-2002. Adv Data. 2004; (347):1-17. View

Masuo K, Mikami H, Ogihara T, Tuck M . Prevalence of hyperinsulinemia in young, nonobese Japanese men. J Hypertens. 1997; 15(2):157-65. DOI: 10.1097/00004872-199715020-00006. View

10.

Schelleman H, Stricker B, de Boer A, Kroon A, Verschuren M, Van Duijn C . Drug-gene interactions between genetic polymorphisms and antihypertensive therapy. Drugs. 2004; 64(16):1801-16. DOI: 10.2165/00003495-200464160-00006. View

11.

Masuo K, Katsuya T, Fu Y, Rakugi H, Ogihara T, Tuck M . Beta2- and beta3-adrenergic receptor polymorphisms are related to the onset of weight gain and blood pressure elevation over 5 years. Circulation. 2005; 111(25):3429-34. DOI: 10.1161/CIRCULATIONAHA.104.519652. View

12.

Cui J, Hopper J, Harrap S . Genes and family environment explain correlations between blood pressure and body mass index. Hypertension. 2002; 40(1):7-12. DOI: 10.1161/01.hyp.0000022693.11752.e9. View

13.

ODea K, Esler M, Leonard P, Stockigt J, Nestel P . Noradrenaline turnover during under- and over-eating in normal weight subjects. Metabolism. 1982; 31(9):896-9. DOI: 10.1016/0026-0495(82)90178-0. View

14.

Masuo K, Kawaguchi H, Mikami H, Ogihara T, Tuck M . Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation. Hypertension. 2003; 42(4):474-80. DOI: 10.1161/01.HYP.0000091371.53502.D3. View

15.

Leineweber K . Beta-adrenergic receptor polymorphism in human cardiovascular disease. Ann Med. 2004; 36 Suppl 1:64-9. DOI: 10.1080/17431380410032544. View

16.

Ward K, Sparrow D, Landsberg L, Young J, Vokonas P, Weiss S . Influence of insulin, sympathetic nervous system activity, and obesity on blood pressure: the Normative Aging Study. J Hypertens. 1996; 14(3):301-8. DOI: 10.1097/00004872-199603000-00005. View

17.

Jia H, Sharma P, Hopper R, Dickerson C, Lloyd D, Brown M . beta2-adrenoceptor gene polymorphisms and blood pressure variations in East Anglian Caucasians. J Hypertens. 2000; 18(6):687-93. DOI: 10.1097/00004872-200018060-00005. View

18.

Strazzullo P, Iacone R, Siani A, Cappuccio F, Russo O, Barba G . Relationship of the Trp64Arg polymorphism of the beta3-adrenoceptor gene to central adiposity and high blood pressure: interaction with age. Cross-sectional and longitudinal findings of the Olivetti Prospective Heart Study. J Hypertens. 2001; 19(3):399-406. DOI: 10.1097/00004872-200103000-00007. View

19.

Ryden M, Hoffstedt J, Eriksson P, Bringman S, Arner P . The Arg 389 Gly beta1-adrenergic receptor gene polymorphism and human fat cell lipolysis. Int J Obes Relat Metab Disord. 2001; 25(11):1599-603. DOI: 10.1038/sj.ijo.0801815. View

20.

Pulkkinen A, Kareinen A, Saarinen L, Heikkinen S, Lehto S, Laakso M . The codon 64 polymorphism of the beta3-adrenergic receptor gene is not associated with coronary heart disease or insulin resistance in nondiabetic subjects and non-insulin-dependent diabetic patients. Metabolism. 1999; 48(7):853-6. DOI: 10.1016/s0026-0495(99)90218-4. View